Explore the retrospective, cross-sectional study describing the treatment patterns of Oral Glucose-Lowering Drugs in Asian population, using the JADE (Joint Asia Diabetes Evaluation) Register.
Get to know about the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial, designed to assess the effects on major vascular outcomes of lowering the glycated hemoglobin value in patients with type 2 diabetes.
Learn more about the retrospective study comparing the effectiveness of gliclazide MR 60 mg versus sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled T2D.
